Key statistics
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | -- |
| Low | -- |
| Bid | -- |
| Offer | -- |
| Previous close | -- |
| Average volume | -- |
|---|---|
| Shares outstanding | 49.22m |
| Free float | 48.72m |
| P/E (TTM) | -- |
| Market cap | 9.04bn USD |
| EPS (TTM) | -1.56 USD |
Data delayed at least 15 minutes.
More ▼
Press releases
- Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
- Charles River Enters Manufacturing Collaboration with Gazi University
- Charles River Laboratories Provides Business Updates
- Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan
- Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
- Charles River Laboratories to Present at Evercore Healthcare Conference
- Charles River Laboratories to Present at Jefferies Global Healthcare Conference
More ▼
